COMMUNIQUÉS West-GlobeNewswire

Nightstar Therapeutics plc Announcement of Expiry of HSR Waiting Period and Satisfaction of Antitrust Condition
16/04/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT [...]
Marrone Bio Innovations announces distribution partnership in Western Canada
16/04/2019
TerraLink to Distribute Regalia Maxx Biofungicide in Western Canada DAVIS, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection [...]
Zosano Announces the Publication of an Analysis of Acute Treatments for Migraine in Headache: The Journal of Head and Face Pain
16/04/2019
FREMONT, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced the peer-reviewed publication of a [...]
Helix Sees Triple-Digit Growth as It Looks to Expand in California -- CFN Media
16/04/2019
Seattle, WA, April 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Why Branding Matters in the Cannabis Industry - CFN Media
16/04/2019
SEATTLE, April 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Ultragenyx Announces UX007 Granted Fast Track Designation and Rare Pediatric Disease Designation by U.S. FDA for Treatment of Long-Chain Fatty Acid Oxidation Disorders
16/04/2019
Company on Track to Submit NDA to FDA in Mid-2019 NOVATO, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel [...]
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data
16/04/2019
NEWTON, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Results of Single Center Prospective Study on Delcath’s PHP Therapy Presented at ECIO 2019
16/04/2019
Study by LUMC Shows Overall Survival of 20.3 Months in Patients with Ocular Melanoma Liver Metastases NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company [...]
Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that they will present and host 1x1 and small group meetings at the [...]
HealthLynked Closes Acquisition of Hughes Center Functional Medicine
16/04/2019
NAPLES, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK) (the Company), a leader in digital healthcare technology, announced today that it closed its acquisition of Hughes Center for Functional [...]
Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
16/04/2019
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New [...]
AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations
16/04/2019
WALTHAM, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Nancy Griffith, Ph.D., as vice president, scientific communications and medical operations, [...]
Intra-Cellular Therapies Mourns the Passing of Co-Founder and Nobel Laureate, Dr. Paul Greengard
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, mourns the [...]
IntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active Ingredients
16/04/2019
SAINT LAURENT, Quebec, April 16, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has filed a new non-provisional patent [...]
Profound Medical Announces First-of-its-Kind TULSA-PRO® Installation
16/04/2019
- First Prostate Cancer Treatment Using TULSA-PROÒ and Philips’ New Elition MR Performed in Trier, Germany - TORONTO, April 16, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “ [...]
Entasis Therapeutics Announces the Appointment of Elizabeth Keiley as General Counsel
16/04/2019
WALTHAM, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
aTyr Pharma to Host Inaugural Summit Meeting on Neuropilin-2 (NRP-2) Biology
16/04/2019
Meeting to feature presentations on recent NRP-2-related discoveries by leading research experts in the field SAN DIEGO, April 16, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company [...]
Zimmer Biomet and RTI Surgical® Partner with AAID Foundation to Expand Access to Dental Care for Veterans
16/04/2019
Partnership reinforces shared commitment of Zimmer Biomet and RTI to improve the lives of patients and meet the needs of deserving veterans PALM BEACH GARDENS, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- Zimmer Biomet and [...]
MediPharm Labs Announces DTC Eligibility, Increasing Accessibility for US Investors
16/04/2019
TORONTO, April 16, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]

Pages